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Available online xxxxAims: Atherosclerosis and ischemic heart disease are more common in diabetic patients. Atherosclerosis process
can disturb the normal functioning of the vascular endothelium and increase vessel wall thickness. The aim of
this studywas the comparison of Carotid intima-media thickness (CIMT)with Exercise tolerance test as an alter-
native way to evaluate cardiac ischemia in diabetic patients.
Methods: In a cross-sectional study, 30 diabetic patients with positive exercise test and 30 diabetic patients with
negative exercise test were enrolled. CIMT of the carotid artery in both groups of patients was measured.
Result: CIMT in the patients with positive and negative exercise test were 1.04 ± 0.21 mm and 0.61 ± 0.11 mm,
respectively (P b 0.001). CIMT in positive exercise test group was positively associated with age and negatively
associated with gender, FBS, HDL and LDL cholesterol and in negative exercise group was negatively associated
with gender, age, FBS, HDL and LDL cholesterol.
Conclusion: Considering observed signiﬁcant positive association between CIMTwith result of exercise tolerance
test (ETT) in type 2 diabetic patients, it may possible to use CIMT as an inexpensive and non-invasivemethod for
evaluation of ischemic heart disease in diabetic patients.Iran.
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Diabetes mellitus1. Introduction
Diabetes mellitus is one of the most important and common causes
of chronic kidney disease (CKD), atherosclerosis and coronary artery
disease (CAD) [1]. Two major diabetic complications are micro-
vascular and macro-vascular diseases. Micro-vascular complications of
diabetes are neuropathy, nephropathy and retinopathy [2]; however,
macro-vascular complications of diabetes such as ischemic heart
disease (IHD) andmyocardial infarction (MI), diastolic cardiac dysfunc-
tion, sudden cardiac death, peripheral artery disease and cerebrovascu-
lar disease are common in diabetic patients and could be responsible for
increasing rates of morbidity and mortality in these patients [3–7].
Some factors have beenmentioned as risk factors of generalized en-
dothelial dysfunction and vasculopathy in diabetic patients. Hyperten-
sion is a common comorbidity in diabetes, so about 70% of type 2
diabetic patients have hypertension, which may result in endothelial
dysfunction, vascular layer remodeling and increasing of arterial
wall thickness [8]. Renin-angiotensin aldosterone system has also a
major role in the progression of vascular remodeling and diabetice under the CC BY-Nvasculopathy; in fact, angiotensin II could increase the production of
growth factors and reactive oxygen species leading to endothelial dys-
function and progression of atherosclerosis [9]. Hyperglycemia could
also damage the vascular wall via production of advanced glycation
end products (AGEs) and oxidative stress [10]. In addition, cytokines
may also play an important role in producing of endothelial dysfunction
and vascular damage in diabetes [11].
Moreover, one of themost important types of diabetic vasculopathy
is cardiovascular disease (CVD), that some predisposing factors for
development of CVD could be chronic hyperglycemia and AGEs, insulin
resistance, oxidative stress and chronic low grade inﬂammation [2,12].
Hyperlipidemia is also prevalent among diabetic patients which may
increase the risk of cardiovascular complications [13].
Electrocardiography, Echocardiography, exercise test, cardiac nu-
clear scan and angiography are used for evaluation of ischemic heart
disease (IHD) in diabetic patients [14–16]. Furthermore, coronary angi-
ography is themost accruablemethod for assessment of IHD, but it is in-
vasive and has some complications [17]. Exercise tolerance test (ETT),
however, is a noninvasive, practical and inexpensive and relatively
accurate test for evaluation of IHD [18]. Some indications of ETT are in-
deed the assessment of chest pain in the patients with moderate risk of
IHD, risk assessment after MI, evaluation of therapeutic response afterC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Mean ± standard deviation of CIMT in the positive and negative patients.
Group Positive ET Negative ET
CIMT (mm) 1.04 ± 0.21 0.61 ± 0.21
P b0.001
Sex Male Female Male Female
CIMT (mm) 98 ± 22 1.08 ± 0.20 0.63 ± 0.14 0.60 ± 0.09
P value 0.19 0.58
Table 2
Comparison ofMean± standard deviation of FBS, HDL and LDL cholesterol in the negative
and positive ET patients.
Variable All patients Group P value
Positive ET Negative ET
FBS 145.86 ± 56.64 136.03 ± 45.13 155.70 ± 6549 0.18
HDL cholesterol 43.85 ± 9.89 42.54 ± 11.13 45.16 ± 8.45 0.30
LDL cholesterol 94.71 ± 35.94 94.63 ± 33.48 94.80 ± 38.82 0.18
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assessment. However, ETT has also some limitations; for example, it
is contraindicated in the patients with acute myocardial infarction
(AMI), aortic dissection, severe aortic stenosis, acute pulmonary embo-
lism or infarction and severe heart failure [19]. ETT may also lead to MI
or death in about 0.04% of cases [20].
Carotid artery intima media thickness (CIMT) is the distance be-
tween intima layer and adventitial layer of carotid artery and measures
by M-mode ultrasonography which has been used for evaluation of
presence and severity of atherosclerosis [21]. Increasing CIMT could be
due to hypertrophy of intima, media or two layers. CIMT can also be
measured at the site of common carotid artery, bifurcation of carotid
artery or proximal site of internal carotid artery, in the right side or
mean value of bilateral right and left side [22]. Moreover, in middle
age patients, mean CIMT of 0.6–0.7 mm are usually considered as nor-
mal and CIMT value N1 mm is a marker of atherosclerosis and probably
IHD [23].
Measurement of CIMT is a sensitive and probably speciﬁc method
for evaluation of atherosclerosis and further cardiovascular and cere-
brovascular diseases [24]. CIMT may be also associated with micro-
vascular complications of diabetes such as retinopathy [25]. However,
there are some studies about association of CIMT with occurrence of
coronary artery event; for example, Salonen and colleagues, in the
study on 1288 patients reported two fold rising of acute coronary events
in patients with higher CIMT [26].
The aim of the study was the evaluation of the results of ETT as an
index of IHD and CIMT as an indicator of generalized atherosclerosis in
the type 2 diabetic patients.
2. Methods and materials
In a cross-sectional study, 60 type 2 diabetic (T2DM) patients in two
equal groups of 30 patients with positive ET and 30 patients with nega-
tive ET were enrolled. At ﬁrst, the records of the patients who recently
had angiographywere evaluated, and 30 diabetic patients with positive
and 30 diabetic patients with negative ETT who fulﬁl inclusion and
exclusion criteria were selected and enrolled in the study. Inclusion
criteriawere T2DMpatients, ability to do the ETT completely, and exclu-
sion criteria were: history of IHD such as MI, cardiac angina, ST-T
change, left bundle branch or atrial ﬁbrillation in the ECG, severe valvu-
lar heart disease before ETT, and lack of cooperation during the study.
During ETT, heart rate, ST-T change and metabolic equivalent
(METS) were evaluated and ST suppression N1 mmwas considered as
positive result. Some criteria for discontinuation of ETT were ST eleva-
tion, reduction of systolic blood pressure N10mm/Hg, ventricular tachy-
cardia or other life threatening ventricular arrhythmia, chest pain,
vertigo and severe fatigue or inability for continuation of procedure.
In addition, ETTwas considered as incomplete andpatients excluded
from study if 85% of maximal heart rate (220 minus age) not achieved.
Demographic characteristics of patients such as age, body mass
index (BMI), duration of diabetes and laboratory data like fasting
blood sugar (FBS) and LDL cholesterol were measured. In all patients,
CIMT was measured at the 2-cm distance of the right common carotid
bifurcation, in the supine position, using a Doppler ultrasonography de-
vice (Siemens G50, Germany) with linear multi-frequencies of 7.5- to
10-MHz probe) by the same sonographist, so he did not know the re-
sults of ETT of the patients. All data were collected and were entered
to SPSS (version 20.0, SPSS Inc., Chicago, IL, USA) and evaluated by
using t-test and Pearson test. All continuous variables were mentioned
as mean ± standard deviation and P b 0.05 was considered as statisti-
cally signiﬁcant. All information was kept conﬁdential, and informed
consent letter was taken from all patients, at the beginning of the
study. The study was funded by the Research and Technology Deputy
of the Shahrekord University of Medical Sciences, Shahrekord, Iran.
The study protocol was approved by the Ethics Committee of the
Shahrekord University of Medical Sciences with No 172.3. Results
Among 60 diabetic patients, 25 patients were male. In the patients
with positive and negative ETT, 14 and 11 patients were male, respec-
tively. In all patients, mean age was 54.75 ± 9.37 year, so in the female
and male patients were 54.65 ± 9.07 and 54.88 ± 9.96 year, respec-
tively (P = 0.92). Mean age of female and male patients with positive
ETT group were 59.12 ± 8.26 and 58.28 ± 10.23 year, respectively
(P = 0.80) and in the female and male patients with negative ETT
were 50.89 ± 8.12 and 50.54 ± 8.09 year, respectively (P = 0.91).
Mean CIMT in all of the patients was 0.82 ± 0.27 mm; however,
in the positive and negative ET groups were 1.04 ± 0.21 mm and
0.61 ± 0.11 mm, respectively (P b 0.001). There was no signiﬁcant
difference between female and male of positive ETT group based on
CIMT, also there was no difference between female and male among
the negative ETT group based on CIMT (Table 1).
There was no signiﬁcant difference between two groups of the
patients regarding to FBS, HDL and LDL cholesterol (Table 2). (P N 0.05).
4. Discussion
The study showed greater CIMT in diabetic patients with positive ET.
CIMT measurement was used for evaluation of micro-vascular and
macro-vascular complication of diabetes mellitus. Some studies carried
out in this regardwith different and controversial result. For example, in
the study on 152 type 2 diabetic patients, the association of CIMT with
proteinuria was found [27]. In addition, Abdelghaffar and colleagues,
in the study on 40 type 1 diabetic patients showed positive association
of CIMT with retinopathy and neuropathy [28]. Jung and colleagues in
their study on 131 type 2 diabetic patients found no association of
CIMT with nephropathy and neuropathy [29]. Discrepancy between
the results of mentioned studies may be due to difference in age, dura-
tion of diabetes and method of sonography.
About association of CIMTwith macrovascular complications of dia-
betes, there are some other studies. Kota and colleagues in their study
showed that CIMT was greater in diabetic patients compare to normal
subjects; in addition, CIMT had correlationwith LDL cholesterol and his-
tory of cerebrovascular accident [30]. Bernard and colleagues in their
study on 229 patients with cardiovascular risk, showed that CIMT
in the patients with cardiovascular risk was greater than the cases
without risk factor [31]. Sensitivity of ETT was estimated about 60% to
70%, and speciﬁcity about 60% to 80% in various studies. It has some
degree of false positive and false negative results; however, it is an
easy, inexpensive, and non-invasive method for evaluation of ischemic
heart disease [32,33].
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higher CIMT and C– reactive protein (CRP) in patients with acute coro-
nary syndrome and stable angina compared to patients with negative
ET [34]. In 87 patients with inconclusive exercise stress test (EST),
CIMT and myocardial perfusion imaging study (MPS) were done by
C. Y. Karabay and colleagues and they showed higher CIMT in the pa-
tients with positive MPS, so they concluded that CIMT may be used as
an alternative inexpensive method for evaluation of myocardial ische-
mia [35]. In addition, Nagai and colleagues in their study on 398 cases
with 72 asymptomatic patients with positive ET and 38 known cases
of IHD found that CIMT was less in the normal subjects than other
groups [36]. The results of above study about association of CIMT and
ETT were somehow similar to our results.
In the present study,we did notﬁnd the association of CIMTwith age
and sex of the patients; however, Zhao and colleagues in their study on
355 diabetic patients found the increasing CIMT after 4 years follow-up,
as well as higher CIMT in male than female patients [37]. Moreover, in
the study of Abdelghaffar and colleagues in type 1 diabetic patients,
they found signiﬁcant correlation of CIMT with age and male sex [28].
In our study, we showed the lack of association of CIMTwith FBS, LDL
and HDL cholesterol. Similar to our result, Nimkuntod and colleagues in
the study on 302 cases found also no association of CIMT with FBS, HDL
and LDL cholesterol [38]. In addition, in the study on 62 hemodialysis pa-
tients by Abbasi and colleagues, CIMT had not association with fasting
blood sugar (EBS) and serum cholesterol [39]. However, Kota reported a
signiﬁcant association of CIMT with FBS and LDL cholesterol [30] Khan
and colleagues in the studyon40 familial hyperlipidemic patients showed
also an association of CIMT with LDL cholesterol [40]. In Abdelghaffar
study, CIMT had also correlationwith FBS, and LDL cholesterol [28]. Con-
troversy in the results of mentioned studies may be due to race, age and
comorbid diseases of the patients and methodological difference.
The limitations of the studywere small sample size and lack of com-
parison of CIMTwithmore accurate method such as coronary angiogra-
phy, so we recommended applying the studies with larger sample size
and comparison of results of CIMT with exercise test and coronary
artery angiography.
5. Conclusion
The study showed higher CIMT in the diabetic patients with positive
ETT, so CIMT may be used as an inexpensive, non-invasive and reliable
method for screening and evaluation of IHD in diabetic patients.
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